Are 20 human papillomavirus types causing cervical cancer?-Reference-Cited by-同舟云学术

Are 20 human papillomavirus types causing cervical cancer?

Published:2014-11-11 Issue:4 Volume:234 Page:431-435
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Arbyn Marc¹,Tommasino Massimo²,Depuydt Christophe³,Dillner Joakim⁴

Affiliation:

1. Unit of Cancer Epidemiology; Scientific Institute of Public Health Brussels, and University of Antwerp; Antwerp Belgium

2. International Agency for Research on Cancer; Lyon France

3. Department of Clinical and Molecular Pathology, AML; Sonic Healthcare; Antwerp Belgium

4. International HPV Reference Center, Department of Laboratory Medicine and Department of Medical Epidemiology & Biostatistics; Karolinska Institutet; Stockholm Sweden

Funder

7th Framework Program of DG Research of the European Commission CoheaHr Project

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Reference21 articles.

1. Biological agents: a review of human carcinogens;IARC Working Group on the Evaluation of Carcinogenic Risks to Humans;IARC Monogr Eval Carcinog Risks Hum,2012

2. The human papillomavirus family and its role in carcinogenesis;Tommasino;Semin Cancer Biol,2014

3. Comparative analysis of 19 genital human papillomavirus types with regard to p53 degradation, immortalization, phylogeny, and epidemiologic risk classification;Hiller;Cancer Epidemiol Biomarkers Prev,2006

4. E7 properties of mucosal human papillomavirus types 26, 53 and 66 correlate with their intermediate risk for cervical cancer development;Mansour;Virology,2007

5. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study;Sanjose;Lancet Oncol,2010

Cited by 204 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High risk human papillomavirus prevalence and genotype distribution in Reunion Island;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-10

2. Characterization of a triple-type chimeric vaccine against human papillomavirus types 18, 45, and 59;Vaccine;2024-10

3. Criteria for second generation comparator tests in validation of novel HPV DNA tests for use in cervical cancer screening;Journal of Medical Virology;2024-09

4. Comparative Analysis of HPV16 Variants in the Untranslated Regulatory Region, L1, and E6 Genes among Vaccinated and Unvaccinated Young Women: Assessing Vaccine Efficacy and Viral Diversity;Viruses;2024-08-29

5. Prevalence and genotype distribution of HPV combined with cervical pathological results in women from Sichuan, China: A cross‐sectional study based on post‐vaccination period 2019 to 2023;Cancer Medicine;2024-08